Parenteral use of cephradine in the treatment of lower respiratory tract infections: results of two studies.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D001991:Bronchitis / Q000188:drug therapy; D002511:Cephalosporins / Q000008:administration & dosage*; D002512:Cephalothin / Q000008:administration & dosage / Q000627:therapeutic use; D002515:Cephradine / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy; D011704:Pyelonephritis / Q000378:metabolism; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000378:metabolism
D002511:Cephalosporins; D002515:Cephradine; D002512:Cephalothin